198 related articles for article (PubMed ID: 35091755)
1. Multi-antitumor therapy and synchronous imaging monitoring based on exosome.
Qian R; Jing B; Jiang D; Gai Y; Zhu Z; Huang X; Gao Y; Lan X; An R
Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2668-2681. PubMed ID: 35091755
[TBL] [Abstract][Full Text] [Related]
2. Hydrophobic insertion-based engineering of tumor cell-derived exosomes for SPECT/NIRF imaging of colon cancer.
Jing B; Gai Y; Qian R; Liu Z; Zhu Z; Gao Y; Lan X; An R
J Nanobiotechnology; 2021 Jan; 19(1):7. PubMed ID: 33407513
[TBL] [Abstract][Full Text] [Related]
3. Targeted doxorubicin-loaded mesenchymal stem cells-derived exosomes as a versatile platform for fighting against colorectal cancer.
Bagheri E; Abnous K; Farzad SA; Taghdisi SM; Ramezani M; Alibolandi M
Life Sci; 2020 Nov; 261():118369. PubMed ID: 32882265
[TBL] [Abstract][Full Text] [Related]
4. Exosome mimetics derived from bone marrow mesenchymal stem cells ablate neuroblastoma tumor in vitro and in vivo.
Li M; Wang J; Guo P; Jin L; Tan X; Zhang Z; Zhanghuang C; Mi T; Liu J; Wang Z; Wu X; Wei G; He D
Biomater Adv; 2022 Nov; 142():213161. PubMed ID: 36308859
[TBL] [Abstract][Full Text] [Related]
5. Mesenchymal Stem Cell Derived Exosomes as Nanodrug Carrier of Doxorubicin for Targeted Osteosarcoma Therapy via SDF1-CXCR4 Axis.
Wei H; Chen F; Chen J; Lin H; Wang S; Wang Y; Wu C; Lin J; Zhong G
Int J Nanomedicine; 2022; 17():3483-3495. PubMed ID: 35959282
[TBL] [Abstract][Full Text] [Related]
6. Extracellular vesicles-based pre-targeting strategy enables multi-modal imaging of orthotopic colon cancer and image-guided surgery.
Jing B; Qian R; Jiang D; Gai Y; Liu Z; Guo F; Ren S; Gao Y; Lan X; An R
J Nanobiotechnology; 2021 May; 19(1):151. PubMed ID: 34022897
[TBL] [Abstract][Full Text] [Related]
7. Size-adjustable micelles co-loaded with a chemotherapeutic agent and an autophagy inhibitor for enhancing cancer treatment via increased tumor retention.
Rao J; Mei L; Liu J; Tang X; Yin S; Xia C; Wei J; Wan D; Wang X; Wang Y; Li M; Zhang Z; He Q
Acta Biomater; 2019 Apr; 89():300-312. PubMed ID: 30878446
[TBL] [Abstract][Full Text] [Related]
8. In Situ One-Step Fluorescence Labeling Strategy of Exosomes via Bioorthogonal Click Chemistry for Real-Time Exosome Tracking In Vitro and In Vivo.
Song S; Shim MK; Lim S; Moon Y; Yang S; Kim J; Hong Y; Yoon HY; Kim IS; Hwang KY; Kim K
Bioconjug Chem; 2020 May; 31(5):1562-1574. PubMed ID: 32369345
[TBL] [Abstract][Full Text] [Related]
9. AS1411 aptamer-functionalized exosomes in the targeted delivery of doxorubicin in fighting colorectal cancer.
Hosseini NF; Amini R; Ramezani M; Saidijam M; Hashemi SM; Najafi R
Biomed Pharmacother; 2022 Nov; 155():113690. PubMed ID: 36099793
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumor effects of CT-26 derived exosomes enriched by MicroRNA-34a on murine model of colorectal cancer.
Hosseini M; Baghaei K; Hajivalili M; Zali MR; Ebtekar M; Amani D
Life Sci; 2022 Feb; 290():120234. PubMed ID: 34953890
[TBL] [Abstract][Full Text] [Related]
12. PEGylated hydrazided gold nanorods for pH-triggered chemo/photodynamic/photothermal triple therapy of breast cancer.
Xu W; Qian J; Hou G; Wang Y; Wang J; Sun T; Ji L; Suo A; Yao Y
Acta Biomater; 2018 Dec; 82():171-183. PubMed ID: 30336271
[TBL] [Abstract][Full Text] [Related]
13. D-α-tocopherol polyethylene glycol 1000 succinate-modified liposomes with an siRNA corona confer enhanced cellular uptake and targeted delivery of doxorubicin via tumor priming.
Tan X; Fang Y; Ren Y; Li Y; Wu P; Yang X; Liu W
Int J Nanomedicine; 2019; 14():1255-1268. PubMed ID: 30863058
[TBL] [Abstract][Full Text] [Related]
14. Blood TfR+ exosomes separated by a pH-responsive method deliver chemotherapeutics for tumor therapy.
Yang L; Han D; Zhan Q; Li X; Shan P; Hu Y; Ding H; Wang Y; Zhang L; Zhang Y; Xue S; Zhao J; Hou X; Wang Y; Li P; Yuan X; Qi H
Theranostics; 2019; 9(25):7680-7696. PubMed ID: 31695794
[TBL] [Abstract][Full Text] [Related]
15. A Nanodrug Consisting Of Doxorubicin And Exosome Derived From Mesenchymal Stem Cells For Osteosarcoma Treatment In Vitro.
Wei H; Chen J; Wang S; Fu F; Zhu X; Wu C; Liu Z; Zhong G; Lin J
Int J Nanomedicine; 2019; 14():8603-8610. PubMed ID: 31802872
[TBL] [Abstract][Full Text] [Related]
16. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy.
Tian Y; Li S; Song J; Ji T; Zhu M; Anderson GJ; Wei J; Nie G
Biomaterials; 2014 Feb; 35(7):2383-90. PubMed ID: 24345736
[TBL] [Abstract][Full Text] [Related]
17. Identification of Lymphatic and Hematogenous Routes of Rapidly Labeled Radioactive and Fluorescent Exosomes through Highly Sensitive Multimodal Imaging.
Jung KO; Kim YH; Chung SJ; Lee CH; Rhee S; Pratx G; Chung JK; Youn H
Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33105908
[TBL] [Abstract][Full Text] [Related]
18. Cascade-amplifying synergistic effects of chemo-photodynamic therapy using ROS-responsive polymeric nanocarriers.
Sun CY; Cao Z; Zhang XJ; Sun R; Yu CS; Yang X
Theranostics; 2018; 8(11):2939-2953. PubMed ID: 29896295
[TBL] [Abstract][Full Text] [Related]
19. Engineering blood exosomes for tumor-targeting efficient gene/chemo combination therapy.
Zhan Q; Yi K; Qi H; Li S; Li X; Wang Q; Wang Y; Liu C; Qiu M; Yuan X; Zhao J; Hou X; Kang C
Theranostics; 2020; 10(17):7889-7905. PubMed ID: 32685027
[No Abstract] [Full Text] [Related]
20. Doxorubicin and indocyanine green loaded superparamagnetic iron oxide nanoparticles with PEGylated phospholipid coating for magnetic resonance with fluorescence imaging and chemotherapy of glioma.
Shen C; Wang X; Zheng Z; Gao C; Chen X; Zhao S; Dai Z
Int J Nanomedicine; 2019; 14():101-117. PubMed ID: 30587988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]